688062 邁威生物
按盤價 
23.080 +0.330 (+1.451%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -30.841 | -34.542 | -42.206 | -62.027 | -57.700 |
| 總資產報酬率 ROA (%) | -15.506 | -23.217 | -30.741 | -47.591 | -47.399 |
| 投入資產回報率 ROIC (%) | -17.255 | -25.631 | -33.308 | -52.427 | -56.276 | 邊際利潤分析 |
| 銷售毛利率 (%) | 92.460 | 98.928 | 99.745 | 81.022 | 34.672 |
| 營業利潤率 (%) | -490.471 | -823.385 | -3,455.471 | -4,762.015 | -12,139.321 |
| 息稅前利潤/營業總收入 (%) | -475.825 | -851.640 | -3,580.798 | -4,740.602 | -12,161.702 |
| 淨利潤/營業總收入 (%) | -493.292 | -828.261 | -3,455.423 | -4,762.038 | -12,138.884 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 101.334 | 99.315 | 100.790 | 103.896 | 103.499 |
| 價值變動淨收益/利潤總額(%) | 0.361 | 0.445 | -0.187 | -0.499 | -2.411 |
| 營業外收支淨額/利潤總額(%) | 0.299 | 0.257 | -0.001 | 0.000 | -0.004 | 償債能力分析 |
| 流動比率 (X) | 1.398 | 2.508 | 6.241 | 0.905 | 3.999 |
| 速動比率 (X) | 1.253 | 2.313 | 6.063 | 0.757 | 3.790 |
| 資產負債率 (%) | 57.645 | 42.240 | 24.004 | 36.774 | 0.103 |
| 帶息債務/全部投入資本 (%) | 49.873 | 29.073 | 14.780 | 15.183 | 3.578 |
| 股東權益/帶息債務 (%) | 92.600 | 228.261 | 549.751 | 472.519 | 2,691.917 |
| 股東權益/負債合計 (%) | 73.954 | 137.299 | 317.053 | 172.300 | 873.059 |
| 利息保障倍數 (X) | -29.523 | 32.585 | 28.561 | -221.160 | 532.983 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 43.940 | 24.761 | 1.398 | 4.058 | 287.901 |
| 存貨周轉天數 (天) | 4,673.425 | 31,319.667 | 303,610.354 | 4,377.963 | 3,309.889 |
| 備註： | 即時報價更新時間為 20/11/2024 09:50 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
